Scleroderma, Diffuse - 20 Studies Found
Completed |
: Stimulatory Autoantibodies to the Platelet-Derived Growth Factor Receptor (PDGFR) in Patients With Systemic Sclerosis : Systemic Sclerosis : 2008-04-23 |
Recruiting |
: Atorvastatin for Microvascular Endothelial Function and Raynaud in Early Diffuse Scleroderma : Scleroderma : 2015-01-26 :
|
Completed |
: Belimumab for the Treatment of Diffuse Cutaneous Systemic Sclerosis : Systemic Sclerosis : 2012-08-15 : Drug: Belimumab Belimumab (Benlysta®) decreases B-Cell survival and has been FDA approved for the t |
Completed |
: A Study to Evaluate the Safety and Efficacy of Abatacept in Patients With Diffuse Systemic Sclerosis (Scleroderma) :
|
Completed |
: Pulmonary Involvement in Scleroderma: A Clinical Study of the Safety and Efficacy of Mycophenolate Mofetil in Scleroderma Patients With Lung Involvement : Scleroderma, Systemic : 2006-06-02 : Drug: Mycophenolate mofetil |
Active, not recruiting |
: IVIG Treatment in Systemic Sclerosis :
|
Recruiting |
: Autologous Stem Cell Systemic Sclerosis Immune Suppression Trial : Scleroderma : 2011-09-29 :
|
Completed |
: Trial of Topical C-82 in Systemic Sclerosis - A Phase I/II Biomarker and Safety Trial : Systemic Scleroderma : 2015-01-18 :
|
Recruiting |
: Allogeneic Hematopoietic Cell Transplantation After Nonmyeloablative Conditioning for Patients With Severe Systemic Sclerosis :
|
Completed |
: High Dose Cyclophosphamide for Treatment of Scleroderma : Scleroderma : 2007-07-13 : Drug: IV Cyclophosphamide Cyclophosphamide (50 mg/kg) intravenously daily for 4 consecutive days (total |